Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study

By Piek Jurgen   Torrenga Bas   Hermsen Brenda   Verheijen René   Zweemer Ronald   Gille Johan   Kenemans Peter   van Diest Paul   Menko Fred  

Familial Cancer, Vol. 2, Iss. 2, 2003-10 ,pp. : 73-78

Springer Publishing Company

Access to resources Recommend Favorite

BRCA1 Germline Mutations and Polymorphisms in a Clinic-Based Series of Ovarian Cancer Cases: A Gynecologic Oncology Group Study

By Smith S.A.   Richards W.E.   Caito K.   Hanjani P.   Markman M.   DeGeest K.   Gallion H.H.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 586-592

Elsevier

Access to resources Recommend Favorite

Analysis of ERCC1, BRCA1, RRM1 and TUBB3 as predictors of prognosis in patients with non-small cell lung cancer who received cisplatin-based adjuvant chemotherapy: A prospective study

By            

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 299-305

Spandidos Publications

Access to resources Recommend Favorite

The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation

By Møller Pål   Stormorken Astrid   Holmen Marit   Hagen Anne   Vabø Anita   Mæhle Lovise  

Breast Cancer Research and Treatment, Vol. 144, Iss. 3, 2014-04 ,pp. : 607-614

Springer Publishing Company

Access to resources Recommend Favorite

Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study

By Poynter Jenny  

Cancer Causes and Control, Vol. 21, Iss. 6, 2010-06 ,pp. : 839-846

Springer Publishing Company

Access to resources Recommend Favorite